VELDHOVEN, the Netherlands - ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.
| Date | Total repurchased shares | Weighted average price | Total repurchased value |
| 30-Apr-18 | 30,260 | 157.32 | 4,760,602.79 |
| 2-May-18 | 29,865 | 159.43 | 4,761,483.51 |
| 3-May-18 | 29,755 | 160.02 | 4,761,492.55 |
| 4-May-18 | 29,605 | 160.85 | 4,761,831.50 |
ASML's current share buyback program was announced on 17 January 2018, and details are available on our website at https://www.asml.com/investors/share-buyback/en/s25436
This regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr. 596/2014).
| Media Relations Contacts | Investor Relations Contacts |
| Monique Mols, phone +31 6 528 444 18 | Skip Miller, phone +1 480 235 0934 |
| Marcel Kemp, phone +31 40 268 6494 |


Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
World game at war: why some European nations have threatened a World Cup boycott
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 



